MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from at the
market equity...
$400K
Issuance of common stock
under espp
$28K
Net cash provided by
financing activities
$428K
Net (decrease)
increase in cash, cash...
-$15,932K
Canceled cashflow
$428K
Non-cash operating lease
cost
$2,255K
Stock-based compensation
expense
$1,766K
Prepaid expenses and
other current and...
$1,323K
Depreciation and
amortization expense
$781K
Accounts payable
$656K
Accounts receivable due
from spn - related...
-$360K
Net cash (used in)
provided by operating...
-$16,360K
Canceled cashflow
$7,141K
Net (loss) income
-$19,913K
Operating lease
liabilities
-$2,467K
Accrued expenses and
other current and...
-$1,045K
Accounts receivable
$76K
Back
Back
Cash Flow
Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, Inc. (MCRB)
source: myfinsight.com